title: In vivo characterization of the liver fat ¹H MR spectrum.
abstract: A theoretical triglyceride model was developed for in vivo human liver fat (1) H MRS characterization, using the number of double bonds (-CH=CH-), number of methylene-interrupted double bonds (-CH=CH-CH(2)-CH=CH-) and average fatty acid chain length. Five 3 T, single-voxel, stimulated echo acquisition mode spectra (STEAM) were acquired consecutively at progressively longer TEs in a fat-water emulsion phantom and in 121 human subjects with known or suspected nonalcoholic fatty liver disease. T(2)-corrected peak areas were calculated. Phantom data were used to validate the model. Human data were used in the model to determine the complete liver fat spectrum. In the fat-water emulsion phantom, the spectrum predicted by the model (based on known fatty acid chain distribution) agreed closely with spectroscopic measurement. In human subjects, areas of CH(2) peaks at 2.1 and 1.3 ppm were linearly correlated (slope, 0.172; r = 0.991), as were the 0.9 ppm CH(3) and 1.3 ppm CH(2) peaks (slope, 0.125; r = 0.989). The 2.75 ppm CH(2) peak represented 0.6% of the total fat signal in high-liver-fat subjects. These values predict that 8.6% of the total fat signal overlies the water peak. The triglyceride model can characterize human liver fat spectra. This allows more accurate determination of liver fat fraction from MRI and MRS.
authors.affiliation: Department of Radiology, University of California, San Diego, CA 92103-8749, USA.
authors.forename: Gavin
authors.initials: G
authors.lastname: Hamilton
authors.forename: Takeshi
authors.initials: T
authors.lastname: Yokoo
authors.forename: Mark
authors.initials: M
authors.lastname: Bydder
authors.forename: Irene
authors.initials: I
authors.lastname: Cruite
authors.forename: Michael E
authors.initials: ME
authors.lastname: Schroeder
authors.forename: Claude B
authors.initials: CB
authors.lastname: Sirlin
authors.forename: Michael S
authors.initials: MS
authors.lastname: Middleton
mesh_terms: D000293:Adolescent; D000328:Adult; D005223:Fats / Q000032:analysis*; D005234:Fatty Liver / Q000378:metabolism; D005260:Female; D006801:Humans; D008099:Liver / Q000737:chemistry*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D008297:Male; D008962:Models, Theoretical; D065626:Non-alcoholic Fatty Liver Disease; D011446:Prospective Studies; D011522:Protons; D014280:Triglycerides / Q000032:analysis*
chemical_list: D005223:Fats; D011522:Protons; D014280:Triglycerides